Sun Pharma gets FDA green light for generic Glumetza tablets

Press enter to search
Close search
Open Menu

Sun Pharma gets FDA green light for generic Glumetza tablets

By Sandra Levy - 07/25/2018
Sun Pharmaceutical Industries has received the nod from the Food and Drug Association for a generic version of Santarus’ Glumetza (metformin hydrochloride) extended-release tablets in 500-mg and 1000-mg dosage strengths.

The product, which is used to improve glycemic control in adults with Type 2 diabetes, had a market value of $443 million for the 12 months ending April 2018, according to IQVIA data.

RELATED TOPICS